An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil.

Marcin KurzynaKatarzyna Malaczynska-RajpoldAndrzej KotejaAgnieszka PawlakŁukasz ChrzanowskiMichał FurdalZbigniew GąsiorWojciech JachećBożena SobkowiczJustyna NorwaTatiana Mularek-KubzdelaAdam Torbicki

Published in: BMC pulmonary medicine (2017)

In patients with PAH who do not tolerate subcutaneous infusion of treprostinil, the use of the Lenus Pro® implantable pump results in significant subjective improvement of vitality and physical aspect of the HRQoL with acceptable safety profile.

Keyphrases

pulmonary arterial hypertension
pulmonary artery
pulmonary hypertension
anti inflammatory
physical activity
mental health
low dose
high dose
sleep quality
polycyclic aromatic hydrocarbons
coronary artery
replacement therapy